Xi Chen
Fan Zhou2†
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Neurosurgery, The second Affiliated Hospital of Kunming Medical University, Kunming, China
- 2Hematology and Rheumatology Department, The Pu’er People’s Hospital, Pu’er, China
- 3Department of Cardiovascular Surgery, The First People’s Hospital of Yunnan Province, Kunming, China
- 4Institute for Ecological Research and Pollution Control of Plateau Lakes, School of Ecology and Environmental Sciences, Yunnan University, Kunming, China
- 5Department of Respiratory Medicine, Second Hospital of Kunming Medical University, Kunming, China
- 6Kunming College of Life Science, University of Chinese Academy of Sciences, Beijing, China
A Corrigendum on
LncRNA-AC02278.4 is a novel prognostic biomarker that promotes tumor growth and metastasis in lung adenocarcinoma
by Chen X, Zhou F, Ren W, Guo J, Huang X, Pu J, Niu X, Jiang X (2022) Front. Oncol. 12:860961. doi: 10.3389/fonc.2022.860961
In the published article, an author name was incorrectly written as Xin Chen. The correct spelling is Xi Chen.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: lncRNA-AC02278.4, lung adenocarcinoma, prognosis, biomarker, cell proliferation, cell migration
Citation: Chen X, Zhou F, Ren W, Guo J, Huang X, Pu J, Niu X and Jiang X (2024) Corrigendum: LncRNA-AC02278.4 is a novel prognostic biomarker that promotes tumor growth and metastasis in lung adenocarcinoma. Front. Oncol. 14:1390669. doi: 10.3389/fonc.2024.1390669
Received: 23 February 2024; Accepted: 27 February 2024;
Published: 13 March 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Chen, Zhou, Ren, Guo, Huang, Pu, Niu and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiulin Jiang, amlhbmd4aXVsaW5AbWFpbC5raXouYWMuY24=; Xiaoqun Niu, NjczNDA5MjU2QHFxLmNvbQ==; Jun Pu, cHVqdW4zMDNAYWxpeXVuLmNvbQ==
†These authors have contributed equally to this work